BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asselta R, Di Tommaso L, Perrino M, Destro A, Giordano L, Cardamone G, Rubino L, Santoro A, Duga S, Zucali PA. Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature. Thorac Cancer 2021;12:1271-8. [PMID: 33704917 DOI: 10.1111/1759-7714.13765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Perrino M, De Pas T, Bozzarelli S, Giordano L, De Vincenzo F, Conforti F, Digiacomo N, Cordua N, D'Antonio F, Borea F, Santoro A, Zucali PA. Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2-B3) and thymic carcinoma previously treated with chemotherapy. Cancer 2021. [PMID: 34706060 DOI: 10.1002/cncr.33990] [Reference Citation Analysis]
2 Xu S, Li X, Zhang H, Zu L, Yang L, Shi T, Zhu S, Lei X, Song Z, Chen J. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. Front Oncol 2021;11:667148. [PMID: 34307137 DOI: 10.3389/fonc.2021.667148] [Reference Citation Analysis]